Full Text
REGD. No. D. L.-33004/99
The Gazette of India
CG-DL-E-29052026-272914
EXTRAORDINARY
PART II—Section 3—Sub-section (ii)
PUBLISHED BY AUTHORITY
No. 2588]
NEW DELHI, WEDNESDAY, MAY 27, 2026/JYAISTHA 6, 1948
MINISTRY OF CHEMICALS AND FERTILIZERS
(Department of Pharmaceuticals)
(NATIONAL PHARMACEUTICAL PRICING AUTHORITY)
ORDER
New Delhi, the 27th May, 2026
S.O. 2681(E).- In implementation of directions of review order issued by the Department of
Pharmaceuticals (DOP) under para 31 of Drugs (Prices Control) Order, 2013 vide order specified in
column (7) of the table below and in exercise of the powers conferred by paragraphs 4, 6, 10, 11, 14, 16, 17
and 18 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and
S.O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals
and Fertilizers, and in supersession of the Order of the Government of India in the Ministry of Chemicals
and Fertilizers (National Pharmaceutical Pricing Authority) S.O. No. and date specified in the Column (8)
of the table, the National Pharmaceutical Pricing Authority, hereby fixes/revises the price including WPI
impact @0.64956% for the year 2026 as specified in column (6) of the table herein below as ceiling price
exclusive of Goods and Services Tax applicable, if any, in respect of the Scheduled formulation specified
in the corresponding entry in column (2) of the said Table with the dosage form & strength and unit
specified respectively in the corresponding entries in columns (3) and (4) thereof:
TABLE
+-----+--------------------+-------------------------+------+-----------------------------------+-----------------------------------------------------+-----------------------------+-------------------------------------+
| Sl. | Medicines | Dosage form & Strength | Unit | Ceiling Price under NLEM, | Revised Ceiling price based on Review Order & | Review Order number and date| Existing SO number and date |
| No. | | | | 2022 (Rs.) | considering WPI @0.64956% (Rs.) | | |
+=====+====================+=========================+======+===================================+=====================================================+=============================+=====================================+
| (1) | (2) | (3) | (4) | (5) | (6) | (7) | (8) |
+-----+--------------------+-------------------------+------+-----------------------------------+-----------------------------------------------------+-----------------------------+-------------------------------------+
| 1. | Benzathine | Powder for Injection | 1 | 11.97 | 13.42 | 31015/06/2024- | 1575(E) dated |
| | benzylpenicillin | 6 lac units | Vial | | | Pricing dated | 25.03.2026 (Sl. No. 95) |
| | | | | | | 20.03.2026 | |
+-----+--------------------+-------------------------+------+-----------------------------------+-----------------------------------------------------+-----------------------------+-------------------------------------+
Note:
(a) All manufacturers of scheduled formulations, selling the branded or generic or both the versions of
scheduled formulations at a price higher than the ceiling price (plus Goods and Services Tax as applicable)
so fixed and notified by the Government, shall revise the prices of all such formulations downward not
exceeding the ceiling price specified in column (6) in the above table plus Goods and Services Tax as
applicable, if any.
(b) All the existing manufacturers of above-mentioned scheduled formulations having MRP lower than the
ceiling price specified in column (6) in the above table plus Goods and Services Tax as applicable, if any,
shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013.
(c) The manufacturers may add Goods and Services Tax only if they have paid actually or if it is payable to
the Government on the ceiling price mentioned in column (6) of the above said table.
(d) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned
manufacturer in accordance with the ceiling price specified in column (6) of the above table as per
provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall
issue a price list in Form-V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA
through IPDMS and submit a copy to State Drug Controller and dealers.
(e) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary
price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries
on business in a manner so as to be easily accessible to any person wishing to consult the same.
(f) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in
the above table launches a new drug as per paragraph 2(1)(u) of the DPCO, 2013 such existing
manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified
under Schedule-II of the DPCO, 2013.
(g) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in
respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO,
2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled
formulation shall furnish information to the NPPA, in respect of discontinuation of production and / or
import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to
the intended date of discontinuation.
(h) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to
deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices
Control) Order, 2013 read with Essential Commodities Act, 1955.
(i) Consequent to the issue of ceiling prices of such formulations as specified in column (2) of the above table
in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said
date of notification, stand(s) superseded.
[F. No. 8(146)/2026/D.P./NPPA-Div.-II]
BHIVA RAM YADAV, Assistant Director
Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064
and Published by the Controller of Publications, Delhi-110054.
KUMER
CHAND
MEENA
Digitally signed by
KUMER CHAND MEENA
Date: 2026.05.29
14:32:05 +05'30'
Login to read full text